Cambridge Healthtech Institute’s Inaugural

Digital Therapeutics

Integrating Evidence-Based and Clinically-Validated DTx into Medicine

June 2-4, 2020


Digital therapeutics present an opportunity for a new class of medicine, which utilizes digital technology to deliver evidence-based therapeutic intervention and can be applied independently or in combination with existing medications or devices. As the pharmaceutical and biotech companies race to enter this new market, challenges and best practices related to design and implementation, clinical validation, data security and commercialization need to be addressed. The Inaugural Digital Therapeutics meeting will convene the thought leaders from pharma and tech companies, leading academic and clinical institutes, regulatory and health insurance providers to work together to bring Digital Therapeutics to the patient.

Preliminary Agenda

Tuesday, June 2

PLENARY SESSION: DIGITAL TRANSFORMATION IN HEALTHCARE

Bringing Digital to Life: Transforming Healthcare and Patient Experience Using Human-Centered Design and Digital Solutions

Neil Gomes, MBA, Med, CSM, CSPO, Executive Vice President, Tech, Innovation & Consumer Experience, Enterprise Chief Digital Officer, Thomas Jefferson University & Jefferson Health

Driving Digital Transformation Success

Claus Jensen, PhD, Chief Digital Officer & Head of Technology, Memorial Sloan Kettering Cancer Center

Talk Title to be Announced

Joseph C. Kvedar, MD, Professor, Dermatology, Harvard Medical School; Senior Advisor, Virtual Care, Partners HealthCare

Delivering Digital Health in a Consumer Health World

Chet Robson, DO, MHCDS, FAAFP, Chief Clinical Officer, Walgreens

The Future of Health has Arrived: The Rise of Smart Health Communities

Asif Dhar, MD, MBA, Chief Health Informatics Officer, Principal, Deloitte Consulting LLP

Partnering Strategies for PRESCRIPTION DIGITAL THERAPEUTICS

Prescription DTx

Alex Waldron, Chief Strategy Officer, Pear Therapeutics

PANEL DISCUSSION: Partnering Strategies for Digital Therapeutics

Moderator: Alex Waldron, Chief Strategy Officer, Pear Therapeutics


PLENARY SESSION: BRIDGING SILOS: AN INTEGRATED APPROACH TO DIGITAL HEALTH

Commercialization, Regulatory and Partnering Strategies with Provider, Payers, Hub, Industry for Digital

Karan Arora, MBA, Chief Commercial Digital Officer, Global Vice President, AstraZeneca

PANEL DISCUSSION: An Integrated Approach to Data Silos, Collaboration and Patient-Centricity

 

Wednesday, June 3

PLENARY Session: Digital Health Innovation

PANEL DISCUSSION: Investing in Digital Health Innovation

Moderator: Lisa Suennen, Lead, Digital & Technology Group, Manatt Ventures; Managing Director, Manatt Health
Panelists:
David Kim, Managing Director, DigiTx
Additional Panelists to be Announced

Delivering Global Comprehensive Virtual Care at Scale

Lewis Levy, MD, FACP, CMO, Teladoc

 

Additional Company Presentations to be Announced

DIGITAL COMPANIONS FOR DISEASE MANAGEMENT AND Rx COMPLIANCE

Digital Therapeutics as Companion to Pharmaceuticals: Lessons Learned and Perspectives

Pierre Leurent, CEO, Voluntis

 

Additional Presentations to be Announced

DTx COMMERCIALIZATION STRATEGIES: MARKET ACCESS AND VALUE MODELS

Partnerships to Commercialize Digital Therapeutics

Adam Kaufman, PhD, President & CEO, Canary Health

Challenges and Potential Solutions in the Commercialization of Digital Therapeutics

David O'Reilly, Chief Platform Officer, Proteus Digital Health

PANEL DISCUSSION: Commercialization Strategies for Digital Therapeutics

Moderator: Adam Kaufman, PhD, President & CEO, Canary Health

 

Thursday, June 4

Evidence-Based, Personalized Digital Therapeutics for Chronic Conditions

Beyond DTx - Engaging the Patient Holistically to Optimize Outcomes

Olivier Jarry, Chief Commercial Officer, President, DarioHealth Corp

Digital Therapeutics for Mental Health: Improving Outcomes, Access and Scale for Mental Healthcare

Ken Cahill, CEO, SilverCloud Health

Plenary Session: EVIDENCE-Based DIGITAL MEDICINE

Talk Title to be Announced

Ashish Atreja, MD, MPH, Assistant Professor, Chief Innovation Officer, Medicine, Icahn School of Medicine at Mount Sinai

PANEL DISCUSSION: Real World Impact of Digital Medicine

Moderator: Ashish Atreja, MD, MPH, Assistant Professor, Chief Innovation Officer, Medicine, Icahn School of Medicine at Mount Sinai




For more details on the conference, please contact:
Julia Boguslavsky

Executive Director, Conferences

Cambridge Healthtech Institute
Email: juliab@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-K

Jon Stroup

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: 781-972-5483
Email: jstroup@healthtech.com

 

Companies L-Z

Joseph Vacca, M.S.

Director, Business Development

Cambridge Healthtech Institute

Phone: 781-972-5431
Email: jvacca@healthtech.com